Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.084 | 0.6 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |